BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION | Secondary Sources | Westlaw

BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION, Secondary Sources
Skip Page Header

BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION

10 No. 12 ANSLRR 17Lyle Roberts, Esq., Paul Chalmers, Esq., and Gerard Stegmaier, Esq.* Andrews Securities Litigation and Regulation Reporter (Approx. 8 pages)

BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION

10 No. 12 ANSLRR 17Lyle Roberts, Esq., Paul Chalmers, Esq., and Gerard Stegmaier, Esq.* Andrews Securities Litigation and Regulation Reporter (Approx. 8 pages)

10 No. 12 Andrews Sec. Litig. & Reg. Rep. 17
Andrews Securities Litigation and Regulation Reporter
*1 October 20, 2004
Commentary
Lyle Roberts, Esq., Paul Chalmers, Esq., and Gerard Stegmaier, Esq.*aa1
Copyright © 2004 West, a Thomson business.

BROUDO V. DURA PHARMACEUTICALS: HIGH COURT WADES INTO MURKY WATERS OF SECURITIES FRAUD LITIGATION

Securities fraud litigation is a growth business. On average, private securities class actions are filed against 200 companies every year. The federal government continues to increase its scrutiny of companies, with private litigation often following...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.